Precedent Wealth Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.18M Buy
33,746
+2,839
+9% +$271K 0.49% 64
2026
Q2
$2.62M Buy
30,907
+2,945
+11% +$238K 0.43% 68
2026
Q1
$1.98M Buy
27,962
+1,584
+6% +$119K 0.4% 76
2025
Q4
$2.08M Buy
26,378
+1,848
+8% +$146K 0.44% 71
2025
Q3
$2.02M Buy
24,530
+1,459
+6% +$115K 0.45% 68
2025
Q2
$1.86M Buy
23,071
+2,946
+15% +$227K 0.45% 67
2025
Q1
$1.62M Buy
20,125
+2,999
+18% +$249K 0.45% 67
2024
Q4
$1.4M Buy
17,126
+300
+2% +$25K 0.46% 63
2024
Q3
$1.39M Buy
16,826
+1,831
+12% +$137K 0.46% 58
2024
Q2
$1.05M Buy
14,995
+856
+6% +$61.1K 0.42% 64
2024
Q1
$1.05M Buy
14,139
+1,200
+9% +$83.6K 0.45% 56
2023
Q4
$856K Buy
+12,939
New +$810K 0.43% 57

Other funds holding MET

Precedent Wealth Partners's MET Position: Q3 2026 in Review

Precedent Wealth Partners increased its MetLife (MET) stake by 9.2% in Q3 2026, buying an estimated $271K and bringing the position to 33,746 shares worth $3.18M. The position accounts for 0.49% of the portfolio, ranked #64.

Precedent Wealth Partners first reported a position in MET in Q4 2023 and has held it in 12 quarters since. 567 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Precedent Wealth Partners held 33,746 shares of MetLife worth $3.18M as of Q3 2026.
  • Precedent Wealth Partners bought 2,839 MetLife shares in Q3 2026, an estimated $271K.
  • MetLife made up 0.49% of Precedent Wealth Partners's portfolio in Q3 2026, its #64 holding.
  • Precedent Wealth Partners first reported a position in MetLife in Q4 2023 and has held it in 12 quarters since.
  • 567 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Precedent Wealth Partners's 13F filing for Q3 2026, filed 21 Oct 2026.